BAMCO Inc Portfolio holdings
AUM
$36.9B
This Quarter Return
+9.43%
1 Year Return
+31.2%
3 Year Return
+112.46%
5 Year Return
+202.3%
10 Year Return
+748.08%
AUM
$38.7B
AUM Growth
+$38.7B
(+2.6%)
Cap. Flow
-$855M
Cap. Flow
% of AUM
-2.21%
Top 10 Holdings %
Top 10 Hldgs %
44.33%
Holding
344
New
16
Increased
94
Reduced
151
Closed
28
Top Buys
| 1 |
Expedia Group
EXPE
|
$80.2M |
| 2 |
TTAN
ServiceTitan, Inc. Class A Common Stock
TTAN
|
$70.4M |
| 3 |
Macerich
MAC
|
$59.4M |
| 4 |
Kilroy Realty
KRC
|
$58.7M |
| 5 |
Equinix
EQIX
|
$46.6M |
Top Sells
| 1 |
Tesla
TSLA
|
$141M |
| 2 |
Vertiv
VRT
|
$90.9M |
| 3 |
ALTR
Altair Engineering Inc. Class A Common Stock
ALTR
|
$78.6M |
| 4 |
Rexford Industrial Realty
REXR
|
$76.8M |
| 5 |
ANSS
Ansys
ANSS
|
$66.1M |
Sector Composition
| 1 | Consumer Discretionary | 29.88% |
| 2 | Financials | 21.45% |
| 3 | Technology | 20.74% |
| 4 | Real Estate | 8.45% |
| 5 | Healthcare | 8.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
276
Zoetis
ZTS
$67.6B
| $2.04M | 0.01% |
12,500
-4,500
| -26% | -$733K |
|
277
Tenet Healthcare
THC
$16.5B
| $1.96M | 0.01% |
15,500
-9,500
| -38% | -$1.2M |
|
278
HCA Healthcare
HCA
$95.4B
| $1.95M | 0.01% |
6,500
-11,800
| -64% | -$3.54M |
|
279
Manchester United
MANU
$2.73B
| $1.93M | 0.01% |
111,479
| – | – |
|
280
T Rowe Price
TROW
$23.2B
| $1.73M | ﹤0.01% |
15,260
| – | – |
|
281
Ultragenyx Pharmaceutical
RARE
$3.04B
| $1.68M | ﹤0.01% |
40,000
-8,000
| -17% | -$337K |
|
282
Biohaven
BHVN
$1.71B
| $1.64M | ﹤0.01% |
44,000
-1,000
| -2% | -$37.4K |
|
283
Edgewise Therapeutics
EWTX
$1.54B
| $1.6M | ﹤0.01% |
+60,000
| New | +$1.6M |
|
284
Weyerhaeuser
WY
$17.9B
| $1.54M | ﹤0.01% |
+54,548
| New | +$1.54M |
|
285
Blackrock
BLK
$170B
| $1.23M | ﹤0.01% |
1,200
| – | – |
|
286
Victory Capital Holdings
VCTR
$4.71B
| $1.09M | ﹤0.01% |
16,596
| – | – |
|
287
Jack Henry & Associates
JKHY
$11.8B
| $1.05M | ﹤0.01% |
6,000
| – | – |
|
288
Wave Life Sciences
WVE
$1.27B
| $1.05M | ﹤0.01% |
+85,000
| New | +$1.05M |
|
289
CarMax
KMX
$9.04B
| $1.03M | ﹤0.01% |
12,582
-1,516
| -11% | -$124K |
|
290
Essent Group
ESNT
$6.2B
| $1.02M | ﹤0.01% |
18,653
| – | – |
|
291
Kymera Therapeutics
KYMR
$3.1B
| $1.01M | ﹤0.01% |
25,000
| – | – |
|
|
ALX
292
Alexander's
ALX
$1.16B
| $1M | ﹤0.01% |
5,000
| – | – |
|
293
Rocket Pharmaceuticals
RCKT
$358M
| $943K | ﹤0.01% |
75,000
-809,341
| -92% | -$10.2M |
|
294
Rivian
RIVN
$17.5B
| $856K | ﹤0.01% |
64,389
-162,157
| -72% | -$2.16M |
|
295
Home Depot
HD
$406B
| $778K | ﹤0.01% |
2,000
| – | – |
|
296
Equifax
EFX
$29.3B
| $765K | ﹤0.01% |
3,000
+100
| +3% | +$25.5K |
|
297
Berkshire Hathaway Class A
BRK.A
$1.08T
| $681K | ﹤0.01% |
1
| – | – |
|
298
Littelfuse
LFUS
$6.31B
| $668K | ﹤0.01% |
2,836
+519
| +22% | +$122K |
|
299
Genmab
GMAB
$16.7B
| $661K | ﹤0.01% |
31,691
-40,683
| -56% | -$849K |
|
300
Lam Research
LRCX
$124B
| $651K | ﹤0.01% |
9,019
+709
| +9% | +$51.2K |
|